Article Details
Retrieved on: 2022-03-23 02:47:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Affini-T goes further, employing synthetic biology to engineer “switch receptors” that convert the immunosuppressive signals from the tumor into ...
Article found on: medcitynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here